Zhen Kang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhen Kang has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
Guocheng Du
69 shared publicationsJian Chen
45 shared publicationsYang Wang
34 shared publications- Guocheng Du
Science Center for Future Foods Jiangnan University Wuxi China
20 shared publications - Jian Chen
Science Center for Future Foods, Jiangnan University, Wuxi 214122, China
19 shared publications Ruirui Xu
18 shared publications
Latest Publications
- Open Access
- 1 December 2026
- Published by KEAI Publishing in Synthetic and Systems Biotechnology
- Vol. 14, 471-479
Metabolic engineering of Saccharomyces cerevisiae for co-production of ergothioneine, salidroside and gadusol
Ergothioneine (EGT), salidroside and gadusol are high-value cosmetic ingredients valued for their moisturizing, skin-brightening and ultraviolet (UV)-protective properties. Leveraging Saccharomyces cerevisia, a GRAS organism already widely used in cosmetics, we engineered a single strain for their simultaneous co-production. We first identified the 5-histidylcysteine sulfoxide synthase domain reaction as rate-limiting and addressed the poor solubility of ergothioneine biosynthesis protein 1 (EGT1) by screening heterologous homologs and optimizing EGT1 through solubility-enhancing fusions and structure-guided stabilization, increasing EGT titer in shake flask from 34 to 132 mg L−1. Multicopy integration of the optimized pathway into the ribosomal DNA (rDNA) locus further boosted EGT production to 690 mg L−1 in a 5-L bioreactor. Subsequently, biosynthetic pathways for salidroside and gadusol were introduced, yielding a tri-product strain that achieved final titers of 1329 mg L−1 EGT, 224 mg L−1 salidroside and 556 mg L−1 gadusol in fed-batch fermentation. This work establishes a multifunctional yeast cell factory capable of simultaneous co-production of multiple premium cosmetic actives, offering a scalable and sustainable platform for next-generation ingredient development.
- 1 December 2026
- Published by KEAI Publishing in Synthetic and Systems Biotechnology
- Vol. 14, 471-479
Open AccessMetabolic engineering of Saccharomyces cerevisiae for co-production of ergothioneine, salidroside and gadusol
Ergothioneine (EGT), salidroside and gadusol are high-value cosmetic ingredients valued for their moisturizing, skin-brightening and ultraviolet (UV)-protective properties. Leveraging Saccharomyces cerevisia, a GRAS organism already widely used in cosmetics, we engineered a single strain for their simultaneous co-production. We first identified the 5-histidylcysteine sulfoxide synthase domain reaction as rate-limiting and addressed the poor solubility of ergothioneine biosynthesis protein 1 (EGT1) by screening heterologous homologs and optimizing EGT1 through solubility-enhancing fusions and structure-guided stabilization, increasing EGT titer in shake flask from 34 to 132 mg L−1. Multicopy integration of the optimized pathway into the ribosomal DNA (rDNA) locus further boosted EGT production to 690 mg L−1 in a 5-L bioreactor. Subsequently, biosynthetic pathways for salidroside and gadusol were introduced, yielding a tri-product strain that achieved final titers of 1329 mg L−1 EGT, 224 mg L−1 salidroside and 556 mg L−1 gadusol in fed-batch fermentation. This work establishes a multifunctional yeast cell factory capable of simultaneous co-production of multiple premium cosmetic actives, offering a scalable and sustainable platform for next-generation ingredient development.
- Open Access
- 1 December 2026
- Published by KEAI Publishing in Synthetic and Systems Biotechnology
- Vol. 14, 64-76
Engineering a heme-dependent tryptophan hydroxylase pathway in E. coli for enhanced melatonin production
Melatonin is a high-value bioactive indoleamine broadly applied in the pharmaceutical, food and nutraceutical industries, yet its microbial production remains constrained by pathway complexity and low enzymatic efficiency. Here, a streamlined melatonin biosynthetic pathway was established in Escherichia coli by introducing the heme-dependent tryptophan hydroxylase Luz15. We further enhanced the intracellular heme availability and increased melatonin production by 111.45%. Fusion-tag engineering improved the solubility of all heterologous enzymes and boosted production by 50.64%. Structure-guided rational design of Luz15 subsequently yielded a beneficial D299S/W376H mutant, enhancing hydroxylation activity and contributing a 33.81% increase. To divert metabolic flux toward melatonin, a high-producing chassis was constructed via gene-editing and systematic sRNA library screening. The final strain produced 753.78 mg/L melatonin in a 5-L fed-batch bioreactor from glucose, a 38.78-fold improvement over the initial. This study establishes an efficient and scalable microbial platform for the sustainable biosynthesis of melatonin and other hydroxylated tryptophan-derived compounds.
- 1 December 2026
- Published by KEAI Publishing in Synthetic and Systems Biotechnology
- Vol. 14, 64-76
Open AccessEngineering a heme-dependent tryptophan hydroxylase pathway in E. coli for enhanced melatonin production
Melatonin is a high-value bioactive indoleamine broadly applied in the pharmaceutical, food and nutraceutical industries, yet its microbial production remains constrained by pathway complexity and low enzymatic efficiency. Here, a streamlined melatonin biosynthetic pathway was established in Escherichia coli by introducing the heme-dependent tryptophan hydroxylase Luz15. We further enhanced the intracellular heme availability and increased melatonin production by 111.45%. Fusion-tag engineering improved the solubility of all heterologous enzymes and boosted production by 50.64%. Structure-guided rational design of Luz15 subsequently yielded a beneficial D299S/W376H mutant, enhancing hydroxylation activity and contributing a 33.81% increase. To divert metabolic flux toward melatonin, a high-producing chassis was constructed via gene-editing and systematic sRNA library screening. The final strain produced 753.78 mg/L melatonin in a 5-L fed-batch bioreactor from glucose, a 38.78-fold improvement over the initial. This study establishes an efficient and scalable microbial platform for the sustainable biosynthesis of melatonin and other hydroxylated tryptophan-derived compounds.
- Open Access
- 10 July 2026
- Published by Wiley in Advanced Science
- Vol. 13 (55) , e76499
Design and Engineering of an Artificial Bifunctional N ‐Deacetylase/ N ‐Sulfotransferase for the Biosynthesis of N ‐Sulfated Heparosan
Heparin is a widely used anticoagulant, while its traditional animal‐derived production faces significant challenges in safety and scalability. The active expression of the initiating‐step bifunctional enzyme N ‐deacetylase/ N ‐sulfotransferase (NDST) in bacteria remains a key bottleneck in heparin biosynthesis. Here, we firstly mined and characterized diverse polysaccharide N ‐deacetylases (NDases) in Escherichia coli and revealed several NDases that are active toward the deacetylation of heparosan. An artificial ND Dr ‐RL‐ST was designed and constructed by fusing an active NDase with a heterogenous NST domain. The ND Dr –MEc /ST variant with a 7.48‐fold improvement in catalytic efficiency was engineered by combining dynamic cross‐correlation analysis, sequence consensus analysis, and mutation‐effect prediction with sequential linker optimization and rational mutagenesis, resulting in enhanced substrate binding, active‐site stabilization, and improved inter‐domain coordination. ND Dr –MEc /ST efficiently converted heparosan to N ‐sulfated polysaccharide with a sulfation degree of 82.8%. The results highlighted the critical role of N ‐sulfotransferase interaction with ND Dr domain in stabilizing the catalytic conformation essential for bifunctional enzyme activity. Moreover, this work also provided valuable insights for the rational design of artificial multifunctional enzymes for polysaccharide modification.
- 10 July 2026
- Published by Wiley in Advanced Science
- Vol. 13 (55) , e76499
Open AccessDesign and Engineering of an Artificial Bifunctional N ‐Deacetylase/ N ‐Sulfotransferase for the Biosynthesis of N ‐Sulfated Heparosan
Heparin is a widely used anticoagulant, while its traditional animal‐derived production faces significant challenges in safety and scalability. The active expression of the initiating‐step bifunctional enzyme N ‐deacetylase/ N ‐sulfotransferase (NDST) in bacteria remains a key bottleneck in heparin biosynthesis. Here, we firstly mined and characterized diverse polysaccharide N ‐deacetylases (NDases) in Escherichia coli and revealed several NDases that are active toward the deacetylation of heparosan. An artificial ND Dr ‐RL‐ST was designed and constructed by fusing an active NDase with a heterogenous NST domain. The ND Dr –MEc /ST variant with a 7.48‐fold improvement in catalytic efficiency was engineered by combining dynamic cross‐correlation analysis, sequence consensus analysis, and mutation‐effect prediction with sequential linker optimization and rational mutagenesis, resulting in enhanced substrate binding, active‐site stabilization, and improved inter‐domain coordination. ND Dr –MEc /ST efficiently converted heparosan to N ‐sulfated polysaccharide with a sulfation degree of 82.8%. The results highlighted the critical role of N ‐sulfotransferase interaction with ND Dr domain in stabilizing the catalytic conformation essential for bifunctional enzyme activity. Moreover, this work also provided valuable insights for the rational design of artificial multifunctional enzymes for polysaccharide modification.
- Open Access
- 5 July 2026
- Published by Elsevier in SSRN Electronic Journal
Engineering Multifunctional Proteoglycan Hydrogels through Supramolecular Hyaluronan-Protein Self-Assembly
Hydrogels have emerged as powerful biomaterial platforms for advanced wound care, however, it remains a major challenge to achieve rapid hemostasis, durable wet-tissue adhesion, infection control, and active tissue regeneration within a single crosslinker-free material system. Here, we construct an artificial proteoglycan hydrogel through the electrostatic co-assembly of hyaluronan and positively charged protamine. Further incorporation of an engineered adhesive protein reinforces interfacial tissue bonding, endowing the hydrogel with high mechanical robustness, intrinsic self-healing capability, and broad-spectrum substrate adhesion. Notably, the hydrogel exhibits an adhesion strength of 51.2 kPa on porcine skin and can firmly adhere to visceral tissues. The adhesion-enhanced hydrogel also displays favorable antibacterial activity, excellent biocompatibility, and rapid hemostatic performance, which effectively accelerates the healing process of full-thickness skin wounds. Overall, this work integrates coacervate-driven assembly with programmable bioadhesive protein engineering to develop a multifunctional tissue adhesive platform via a simple, low-cost, crosslinker-free strategy, demonstrating great promise for next-generation regenerative biomaterials.
- 5 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEngineering Multifunctional Proteoglycan Hydrogels through Supramolecular Hyaluronan-Protein Self-Assembly
Hydrogels have emerged as powerful biomaterial platforms for advanced wound care, however, it remains a major challenge to achieve rapid hemostasis, durable wet-tissue adhesion, infection control, and active tissue regeneration within a single crosslinker-free material system. Here, we construct an artificial proteoglycan hydrogel through the electrostatic co-assembly of hyaluronan and positively charged protamine. Further incorporation of an engineered adhesive protein reinforces interfacial tissue bonding, endowing the hydrogel with high mechanical robustness, intrinsic self-healing capability, and broad-spectrum substrate adhesion. Notably, the hydrogel exhibits an adhesion strength of 51.2 kPa on porcine skin and can firmly adhere to visceral tissues. The adhesion-enhanced hydrogel also displays favorable antibacterial activity, excellent biocompatibility, and rapid hemostatic performance, which effectively accelerates the healing process of full-thickness skin wounds. Overall, this work integrates coacervate-driven assembly with programmable bioadhesive protein engineering to develop a multifunctional tissue adhesive platform via a simple, low-cost, crosslinker-free strategy, demonstrating great promise for next-generation regenerative biomaterials.
- Open Access
- 4 June 2026
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 92 (7) , e0078626
Condensate-based sequestration enables high-efficiency synthesis of mussel foot protein Mcofp-3
Mussel foot proteins (Mfps) hold immense potential for medicine and bioengineering, owing to their exceptional adhesion and biocompatibility. However, traditional extraction from mussels is low-yield and ecologically unsustainable. While microbial synthesis offers a green alternative, the intrinsic hydrophobicity and adhesiveness of Mfps often induce severe host cytotoxicity, resulting in low yields. Initially, attempts to express Mcofp-3 in Escherichia coli were limited to 60 mg L −1 due to such cytotoxic effects. To overcome this bottleneck, we developed a hyaluronic acid (HA)-driven “condensate-based sequestration” strategy. This approach leverages electrostatic interactions to sequester Mcofp-3 into condensates, thereby shielding the host cells and alleviating metabolic stress. This strategy significantly restored cell viability, increasing the titer to 460 mg L −1 in shake flasks. Moreover, the process was successfully scaled up to a 50 L fed-batch fermentation, achieving a final titer of 1.6 g L −1 . Following production, in vitro 3,4-dihydroxyphenylalanine (DOPA) modification was performed using immobilized TyrVs-CipA, yielding functional Mcofp-3 that exhibited anti-inflammatory activity and enhanced cell migration capabilities. This work establishes a versatile, green paradigm for the high-yield production of proteins with low yields and increased toxicity in bacterial expression systems. IMPORTANCE: Mussel foot proteins (Mfps) are prized bio-adhesives for medical applications, yet their supply remains limited. Harvesting mussels is environmentally unsustainable, while microbial synthesis is challenging due to the severe toxicity of these proteins to host cells. In this study, we developed a “condensate-based sequestration” strategy to overcome this bottleneck. By employing hyaluronic acid to isolate the toxic proteins within the bacteria, we shielded the host cells and achieved high-yield production. This approach enabled the gram-scale synthesis of modified Mfps with desirable bioactivity. Beyond synthesizing Mfps, this strategy establishes a versatile, green platform for manufacturing a wide range of other “difficult-to-express” toxic proteins that are currently commercially unviable.
- 4 June 2026
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 92 (7) , e0078626
Open AccessCondensate-based sequestration enables high-efficiency synthesis of mussel foot protein Mcofp-3
Mussel foot proteins (Mfps) hold immense potential for medicine and bioengineering, owing to their exceptional adhesion and biocompatibility. However, traditional extraction from mussels is low-yield and ecologically unsustainable. While microbial synthesis offers a green alternative, the intrinsic hydrophobicity and adhesiveness of Mfps often induce severe host cytotoxicity, resulting in low yields. Initially, attempts to express Mcofp-3 in Escherichia coli were limited to 60 mg L −1 due to such cytotoxic effects. To overcome this bottleneck, we developed a hyaluronic acid (HA)-driven “condensate-based sequestration” strategy. This approach leverages electrostatic interactions to sequester Mcofp-3 into condensates, thereby shielding the host cells and alleviating metabolic stress. This strategy significantly restored cell viability, increasing the titer to 460 mg L −1 in shake flasks. Moreover, the process was successfully scaled up to a 50 L fed-batch fermentation, achieving a final titer of 1.6 g L −1 . Following production, in vitro 3,4-dihydroxyphenylalanine (DOPA) modification was performed using immobilized TyrVs-CipA, yielding functional Mcofp-3 that exhibited anti-inflammatory activity and enhanced cell migration capabilities. This work establishes a versatile, green paradigm for the high-yield production of proteins with low yields and increased toxicity in bacterial expression systems. IMPORTANCE: Mussel foot proteins (Mfps) are prized bio-adhesives for medical applications, yet their supply remains limited. Harvesting mussels is environmentally unsustainable, while microbial synthesis is challenging due to the severe toxicity of these proteins to host cells. In this study, we developed a “condensate-based sequestration” strategy to overcome this bottleneck. By employing hyaluronic acid to isolate the toxic proteins within the bacteria, we shielded the host cells and achieved high-yield production. This approach enabled the gram-scale synthesis of modified Mfps with desirable bioactivity. Beyond synthesizing Mfps, this strategy establishes a versatile, green platform for manufacturing a wide range of other “difficult-to-express” toxic proteins that are currently commercially unviable.
- 13 May 2026
- Published by Elsevier in Trends in Biotechnology
- Vol. 44 (11) , 3284-3304
Multidimensionally engineered Escherichia coli for efficient gadusol biosynthesis with high-throughput quantitative analysis
- 13 May 2026
- Published by Elsevier in Trends in Biotechnology
- Vol. 44 (11) , 3284-3304
Multidimensionally engineered Escherichia coli for efficient gadusol biosynthesis with high-throughput quantitative analysis
- 10 April 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (5) , 2160-2172
Expression Optimization and Semirational Engineering of Ga6 O ST1 for Improved Catalytic Performance in Heparin Biosynthesis
Bioengineered heparin represents a safe and sustainable alternative to animal-derived anticoagulants. However, inefficient 6-O-sulfation catalyzed by heparan sulfate 6-O-sulfotransferase remains a bottleneck hindering the synthesis of heparin. Here, we establish a high-efficiency expression platform for Gallus gallus heparan sulfate 6-O-sulfotransferase 1 (Ga6OST1) in Komagataella phaffii. First, a systematic secretion-engineering strategy established an optimized production chassis with markedly elevated extracellular Ga6OST1 activity. Building on this platform, a semirational design strategy integrating structural modeling, evolutionary analysis, and hotspot prediction identified a triple mutant (MBP-Ga6OST1-A77R/V107L/V248T) with markedly improved properties. This variant exhibited a 2.4-fold increase in specific activity, a 2.3-fold enhancement in catalytic turnover, and a 5.3-fold extension in half-life at 37 °C. Structural analysis and molecular dynamics simulations revealed that cooperative reinforcement of hydrophobic packing and electrostatic networks underlies the observed gains in stability and catalytic durability. Under preparative catalytic conditions, the engineered enzyme displayed enhanced performance toward distinct sulfated heparin precursors, enabling the production of a final product with a 6-O-sulfation degree of 75.7%, comparable to that of porcine intestinal heparin. This work establishes an efficient platform for the production of structurally defined, highly 6-O-sulfated heparin and related derivatives.
- 10 April 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (5) , 2160-2172
Expression Optimization and Semirational Engineering of Ga6 O ST1 for Improved Catalytic Performance in Heparin Biosynthesis
Bioengineered heparin represents a safe and sustainable alternative to animal-derived anticoagulants. However, inefficient 6-O-sulfation catalyzed by heparan sulfate 6-O-sulfotransferase remains a bottleneck hindering the synthesis of heparin. Here, we establish a high-efficiency expression platform for Gallus gallus heparan sulfate 6-O-sulfotransferase 1 (Ga6OST1) in Komagataella phaffii. First, a systematic secretion-engineering strategy established an optimized production chassis with markedly elevated extracellular Ga6OST1 activity. Building on this platform, a semirational design strategy integrating structural modeling, evolutionary analysis, and hotspot prediction identified a triple mutant (MBP-Ga6OST1-A77R/V107L/V248T) with markedly improved properties. This variant exhibited a 2.4-fold increase in specific activity, a 2.3-fold enhancement in catalytic turnover, and a 5.3-fold extension in half-life at 37 °C. Structural analysis and molecular dynamics simulations revealed that cooperative reinforcement of hydrophobic packing and electrostatic networks underlies the observed gains in stability and catalytic durability. Under preparative catalytic conditions, the engineered enzyme displayed enhanced performance toward distinct sulfated heparin precursors, enabling the production of a final product with a 6-O-sulfation degree of 75.7%, comparable to that of porcine intestinal heparin. This work establishes an efficient platform for the production of structurally defined, highly 6-O-sulfated heparin and related derivatives.
- 25 February 2026
- Published by Elsevier in Carbohydrate Polymers
- Vol. 381, 125145
High-molecular weight hyaluronic acid protects against colitis by remodeling microbiota and restoring barrier function
- 25 February 2026
- Published by Elsevier in Carbohydrate Polymers
- Vol. 381, 125145
High-molecular weight hyaluronic acid protects against colitis by remodeling microbiota and restoring barrier function
- 16 January 2026
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 28 (5) , 2220-2234
Design and engineering of biosynthetic and regeneration pathways for central sulfate donors: toward the sustainable production of bioactive sulfated products
PAPS and its precursor APS are central activated sulfur metabolites that link inorganic sulfate assimilation, and advances in their biosynthesis and regeneration enable the efficient and sustainable production of sulfated metabolites.
- 16 January 2026
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 28 (5) , 2220-2234
Design and engineering of biosynthetic and regeneration pathways for central sulfate donors: toward the sustainable production of bioactive sulfated products
PAPS and its precursor APS are central activated sulfur metabolites that link inorganic sulfate assimilation, and advances in their biosynthesis and regeneration enable the efficient and sustainable production of sulfated metabolites.